Informazioni sul prodotto
- N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-Fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]c arbamic acid ethyl ester sulfateSch 530348
- Carbamic acid, N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl ester, sulfate (1:1)
- Carbamic acid, [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl ester, sulfate (1:1)
- Sch 530348
- Vorapaxar sulphate
- Zontivity
Vorapaxar sulfate is a platelet aggregation inhibitor that is used to prevent thrombosis. It inhibits the activation of human platelets by inhibiting the binding of thrombin to its receptor on the surface of platelets, which prevents the production of fibrinogen. Vorapaxar sulfate has been shown to be effective in reducing intracranial haemorrhage and ischaemic attack in patients with stroke or transient ischaemic attack. Vorapaxar sulfate also has anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis.
Proprietà chimiche
Richiesta tecnica su: 3D-FV28721 Vorapaxar sulfate
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
